EV/EBITDA
-1.47
-0.38-34.86%
Thu, 27 Feb 2025 00:59:59 GMT
Summary
- As of February 27, 2025, RENB EV/EBITDA is -1.47, with a fall of -0.38 (-34.86%) during the most recent trading day.
- Over the past year, RENB EV/EBITDA has increased by +6.58 (+81.74%).
- RENB EV/EBITDA is now -194.00% below its all-time high of -0.50.
Performance
RENB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RENB EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -34.9% | +35.4% | +37.0% |
1 m1 month | - | - | +26.1% |
3 m3 months | -98.7% | +116.6% | +118.8% |
6 m6 months | -2.1% | +61.6% | +57.6% |
ytdytd | - | - | +29.6% |
1 y1 year | +81.7% | -43.6% | -49.5% |
5 y5 years | +94.2% | +28.5% | -64.3% |
RENB EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -56.4% | -1.54 | +4.5% | |
3 m | 3-month | -0.74 | -98.7% | -2.83 | +48.1% |
6 m | 6-month | -0.61 | -141.0% | -2.83 | +48.1% |
1 y | 1-year | -0.61 | -141.0% | -9.49 | +84.5% |
3 y | 3-year | -0.50 | -194.0% | -11.41 | +87.1% |
5 y | 5-year | -0.50 | -194.0% | -44.57 | +96.7% |
alltime | all time | -0.50 | -194.0% | -54.58 | +97.3% |
Renovaro Biosciences EV/EBITDA History
Date | Value |
---|---|
2025 | -1.47(-71.9%) |
2023 | -5.24(+835.7%) |
2022 | -0.56(-94.4%) |
Date | Value |
---|---|
2021 | -9.96(-27.2%) |
2020 | -13.68(-66.0%) |
2019 | -40.19(+246.5%) |
2018 | -11.60 |
FAQ
- What is Renovaro Biosciences EV/EBITDA?
- What is the all time high EV/EBITDA for Renovaro Biosciences?
- What is Renovaro Biosciences EV/EBITDA year-on-year change?
What is Renovaro Biosciences EV/EBITDA?
The current EV/EBITDA of RENB is -1.47
What is the all time high EV/EBITDA for Renovaro Biosciences?
Renovaro Biosciences all-time high EV/EBITDA is -0.50
What is Renovaro Biosciences EV/EBITDA year-on-year change?
Over the past year, RENB EV/EBITDA has changed by +6.58 (+81.74%)